Literature DB >> 113347

Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism.

C C Tsai, W P McArthur, P C Baehni, B F Hammond, N S Taichman.   

Abstract

The plaque-derived gram-negative microorganism Y4 identified as a member of the genus Actinobacillus, was tested for a soluble cytotoxic factor(s). Sonication or incubation of viable Y4 microorganisms in distilled water or normal human serum resulted in liberation of a soluble material which was cytotoxic in vitro for human polymorphonuclear leukocytes (PMNs). The Y4 soluble sonic extract was also cytotoxic to human peripheral blood monocytes. However, human lymphocytes, platelets, and fibroblasts, as well as rabbit, rat, and mouse leukocytes and chicken embryo fibroblasts, were not killed by exposure to the Y4 sonic extract. No hemolytic activity was detected in the Y4 sonic extract. No hemolytic activity was detected in the Y4 sonic extract. Consequently, the factor(s) in the Y4 sonic extract was referred to as Y4 leukotoxin. The Y4 leukotoxin was inactive at 4 degrees C, heat sensitive (56 degrees C, 30 min), and inactivated by proteases. The cytotoxic effect of Y4 leukotoxin on PMNs was dose, time, and temperature dependent. The leukotoxin did not bind to viable PMNs at 4 degrees C but did bind to dead PMN membrane components at both 4 and 37 degrees C. The addition of bovine serum albumin (51 mg/ml) to PMN-Y4 leukotoxin cultures inhibited the release of lactate dehydrogenase from the PMNs, but did not prevent the death of the cells as indicated by electron microscopy. Lysosomal markers were released in parallel to the cytoplasmic enzyme lactate dehydrogenase from Y4 leukotoxin-treated PMNs. The addition of 0.02 M ethylenedinitrilotetraacetic acid to these cultures inhibited release of lysosomal markers but enhanced the release of lactate dehydrogenase. These results suggested that a soluble leukotoxin with specificity for only human PMNs and monocytes can be liberated from viable Y4. What role this leukotoxin plays in the pathogenicity of the Y4 microorganism is not yet known. However, this leukotoxin is one of the first materials from a plaque-derived microorganism with a potential role in the pathogenesis of juvenile periodontitis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 113347      PMCID: PMC414468          DOI: 10.1128/iai.25.1.427-439.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Bacterial adherence in oral microbial ecology.

Authors:  R J Gibbons; J V Houte
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

2.  EXPERIMENTAL GINGIVITIS IN MAN.

Authors:  H LOE; E THEILADE; S B JENSEN
Journal:  J Periodontol       Date:  1965 May-Jun       Impact factor: 6.993

3.  The predominant cultivable organisms in juvenile periodontitis.

Authors:  J Slots
Journal:  Scand J Dent Res       Date:  1976-01

4.  Interaction of inflammatory cells and oral bacteria: release of lysosomal hydrolases from rabbit polymorphonuclear leukocytes exposed to gram-positive plaque bacteria.

Authors:  N S Taichman; W P McArthur
Journal:  Arch Oral Biol       Date:  1976       Impact factor: 2.633

5.  Histological changes in experimental periodontal disease in rats mono-infected with a gram-negative organism.

Authors:  J T Irving; M G Newman; S S Socransky; J D Heely
Journal:  Arch Oral Biol       Date:  1975-03       Impact factor: 2.633

6.  Microbial succession in subgingival plaque of man.

Authors:  S K Sterberg; S Z Sudo; L E Folke
Journal:  J Periodontal Res       Date:  1976-09       Impact factor: 4.419

7.  Subgingival microflora and periodontitis.

Authors:  B L Williams; R M Pantalone; J C Sherris
Journal:  J Periodontal Res       Date:  1976-02       Impact factor: 4.419

8.  Bacteriological studies of developing supragingival dental plaque.

Authors:  S S Socransky; A D Manganiello; D Propas; V Oram; J van Houte
Journal:  J Periodontal Res       Date:  1977-03       Impact factor: 4.419

9.  Predominant cultivable microbiota in periodontosis.

Authors:  M G Newman; S S Socransky
Journal:  J Periodontal Res       Date:  1977-03       Impact factor: 4.419

10.  Structure of the microbial flora associated with periodontal health and disease in man. A light and electron microscopic study.

Authors:  M A Listgarten
Journal:  J Periodontol       Date:  1976-01       Impact factor: 6.993

View more
  60 in total

1.  Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans.

Authors:  J Spitznagel; E Kraig; D Kolodrubetz
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

4.  Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  P Kelk; R Claesson; L Hänström; U H Lerner; S Kalfas; A Johansson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.

Authors:  Nataliya V Balashova; Juan A Crosby; Lourdes Al Ghofaily; Scott C Kachlany
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

6.  Novel loop-mediated isothermal amplification method for detection of the JP2 clone of Aggregatibacter actinomycetemcomitans in subgingival plaque.

Authors:  Mitsuko Seki; Knud Poulsen; Dorte Haubek; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

7.  Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface.

Authors:  H Ohta; K Kato; S Kokeguchi; H Hara; K Fukui; Y Murayama
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

9.  Immunohistochemical dynamics of leukotoxin (9,10-epoxy-12-octadecenoic acid) in lungs of rats.

Authors:  W Zhang; M Nagao; T Takatori; K Iwadate; Y Itakura; Y Yamada; H Iwase; T Oono
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

10.  Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line.

Authors:  J J Zambon; C DeLuca; J Slots; R J Genco
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.